Cherubism is a rare autoinflammatory bone disorder that is associated with point mutations in the SH3-domain binding protein 2 (
Virginie Prod’Homme, Laurent Boyer, Nicholas Dubois, Aude Mallavialle, Patrick Munro, Xavier Mouska, Isabelle Coste, Robert Rottapel, Sophie Tartare-Deckert, Marcel Deckert
Title and authors | Publication | Year |
---|---|---|
The bone phenotype associated with cherubism is independent of Caspase-1-dependent inflammasome activation in the mouse
Rabhi BV, Thomasseau S, Decrouy X, Cohen-Solal M, Deckert M, Coudert AE, Brial F |
PLOS ONE | 2025 |
PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy
Matsumoto K, Matsumoto Y, Wada J |
Frontiers in Immunology | 2025 |
Loss-of-function OGFRL1 variants identified in autosomal recessive cherubism families.
Kittaka M, Mizuno N, Morino H, Yoshimoto T, Zhu T, Liu S, Wang Z, Mayahara K, Iio K, Kondo K, Kondo T, Hayashi T, Coghlan S, Teno Y, Doan AAP, Levitan M, Choi RB, Matsuda S, Ouhara K, Wan J, Cassidy AM, Pelletier S, Nampoothiri S, Urtizberea AJ, Robling AG, Ono M, Kawakami H, Reichenberger EJ, Ueki Y |
JBMR Plus | 2024 |
Silencing of SH3BP2 Inhibits Microglia Activation Via the JAK/STAT Signaling in Spinal Cord Injury Models.
Yu M, Wang F, Han K |
Inflammation | 2024 |
Adaptor protein 3BP2 regulates gene expression in addition to the ubiquitination and proteolytic activity of MALT1 in dectin-1–stimulated cells
Tsubokawa A, Chihara K, Chihara Y, Takeuchi K, Fujieda S, Sada K |
The Journal of Biological Chemistry | 2024 |
Tankyrase represses auto-inflammation through the attenuation of TLR2 signaling
Yoshinori Matsumoto, Ioannis Dimitriou, Jose La Rose, Melissa Lim, Susan Camilleri, Napoleon Law, Hibret Adissu, Jiefei Tong, Michael F. Moran, Andrzej Chruscinski, Fang He, Yosuke Asano, Takayuki Katsuyama, Ken-ei Sada, Jun Wada, Robert Rottapel |
Journal of Clinical Investigation | 2022 |
SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis
C Luci, E Vieira, M Bourinet, D Rousseau, S Bonnafous, S Patouraux, L Lefevre, F Larbret, V Prodhomme, A Iannelli, A Tran, R Anty, B Bailly-Maitre, M Deckert, P Gual |
CMGH Cellular and Molecular Gastroenterology and Hepatology | 2021 |
Tlr2/4 ‐Mediated Hyperinflammation Promotes Cherubism‐Like Jawbone Expansion in Sh3bp2 ( P416R ) Knockin Mice
Y Fujii, N Monteiro, S Sah, H Javaheri, Y Ueki, Z Fan, E Reichenberger, I Chen |
JBMR Plus | 2021 |
Investigating global gene expression changes in a murine model of cherubism
T Sharma, J Cotney, V Singh, A Sanjay, EJ Reichenberger, Y Ueki, P Maye |
Bone | 2020 |
Cherubism as a systemic skeletal disease: evidence from an aggressive case
A Morice, A Joly, M Ricquebourg, G Maruani, E Durand, L Galmiche, J Amiel, Y Vial, H Cavé, K Belhous, M Piketty, M Cohen-Solal, A Berdal, C Collet, A Picard, AE Coudert, N Kadlub |
BMC musculoskeletal disorders | 2020 |
Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice: MICROBE-DEPENDENT ALVEOLAR BONE DESTRUCTION IN CHERUBISM MICE
M Kittaka, T Yoshimoto, C Schlosser, M Kajiya, H Kurihara, EJ Reichenberger, Y Ueki |
JBMR Plus | 2020 |
Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2
T Mukai, S Fujita, Y Morita |
Cells | 2019 |
Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice
A Nagasu, T Mukai, M Iseki, K Kawahara, S Tsuji, H Nagasu, Y Ueki, K Ishihara, N Kashihara, Y Morita |
Cells | 2019 |
Alveolar Bone Protection by Targeting the SH3BP2‐SYK Axis in Osteoclasts
M Kittaka, T Yoshimoto, C Schlosser, R Rottapel, M Kajiya, H Kurihara, EJ Reichenberger, Y Ueki |
Journal of Bone and Mineral Research | 2019 |
Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model: A SYK INHIBITOR FOR CHERUBISM TREATMENT
T Yoshimoto, T Hayashi, T Kondo, M Kittaka, EJ Reichenberger, Y Ueki |
Journal of Bone and Mineral Research | 2018 |
RNF146 is an Osteoclastogenic Switch Regulated by RANK Ligand
Yoshinori Matsumoto, Jose La Rose, Oliver A. Kent, Melissa Lim, Adele Changoor, Lucia Zhang, Yaryna Storozhuk, Xiaohong Mao, Marc Grynpas, Feng Cong, Robert Rottapel |
Journal of Clinical Investigation | 2017 |
Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcRγ-mediated phagocytosis and chemokine expression in U937 cells
K Chihara, Y Kato, H Yoshiki, K Takeuchi, S Fujieda, K Sada |
Scientific Reports | 2017 |